| Mean | SD |
---|---|---|
General characteristics | Â | Â |
Age (year) | 75.2 | 8.06 |
BSA (m2) | 1.8 | 0.17 |
Log EUROSCORE (%) | 5.9 | 4.17 |
EUROSCORE II (%) | 2.2 | 1.13 |
SAP (mmHg) | 139.1 | 19.00 |
DAP (mmHg) | 71.3 | 10.03 |
HRÂ (bpm) | 73.5 | 11.92 |
 | n | % |
---|---|---|
Clinical characteristics | Â | Â |
Female sex | 23 | 63 |
CHD (</=50Â % epicardial coronary) | 12 | 33 |
COPD | 8 | 22 |
Anemia | 14 | 38 |
Chronic kidney dis. | 22 | 61 |
Diabetes Mell. | 8 | 22 |
Arterial hypertension | 31 | 86 |
Dyslipidemia | 21 | 58 |
 | n | % |
---|---|---|
Drugs (admission) | Â | Â |
ACE-inhibitors | 15 | 41 |
AT-II-inhibitors | 10 | 27 |
Anti-aldosteronic | 2 | 5 |
Diuretics | 14 | 38 |
Calcium-antagonist | 6 | 10 |
Laboratory data | Mean/Median* | SD/Min–Max** |
---|---|---|
BNPÂ (pg/mL) | 250.9 | 220.4 |
GFRÂ (mL/min/1.73Â m2) | 70.8 | 28.4 |
hsTnTÂ (ng/L) | 30.4 | 26.8 |
miRNA-21 (30 pts) | 2.02* | 0.02–11.26** |